Bionano Genomics
BNGO
Bionano Genomics (BNGO) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- −$0.67
- EPS estimate
- −$0.67
- EPS surprise
- +0.00%
- Revenue surprise
- +8.20%
- Revenue
- $8.2M
- Revenue estimate
- $7.6M
- Reported
- Aug 10, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 10, 2026 | −$0.67 | −$0.67 | +0.00% | $8.2M | SEC |
| Q1 2026 | May 13, 2026 | −$0.88 | −$0.76 | +13.64% | $6.7M | SEC |
| Q4 2025 | Mar 23, 2026 | −$2.48 | −$1.55 | +37.37% | $8.0M | SEC |
| Q3 2025 | Nov 13, 2025 | −$2.08 | −$2.04 | +1.69% | $7.4M | SEC |
| Q2 2025 | Aug 14, 2025 | −$2.66 | −$2.00 | +24.72% | $6.7M | SEC |
| Q1 2025 | May 14, 2025 | −$3.02 | −$1.15 | +61.96% | $6.5M | SEC |
| Q4 2024 | Mar 31, 2025 | −$5.90 | −$12.14 | −105.75% | $8.2M | SEC |
| Q3 2024 | Nov 13, 2024 | −$11.85 | −$31.20 | −163.26% | $6.1M | SEC |
| Q2 2024 | Aug 7, 2024 | −$24.92 | −$14.40 | +42.21% | $7.8M | SEC |
| Q1 2024 | May 8, 2024 | −$38.65 | −$36.00 | +6.85% | $8.8M | SEC |
| Q4 2023 | Mar 5, 2024 | −$52.24 | −$66.90 | −28.06% | $10.7M | SEC |
| Q3 2023 | Nov 8, 2023 | −$58.18 | −$193.20 | −232.08% | $9.3M | SEC |
| Q2 2023 | Aug 9, 2023 | −$62.55 | −$74.40 | −18.95% | $8.7M | SEC |
| Q1 2023 | May 9, 2023 | −$62.72 | −$72.00 | −14.79% | $7.4M | SEC |
| Q4 2022 | Mar 9, 2023 | −$67.44 | −$78.00 | −15.65% | $8.2M | SEC |
| Q3 2022 | Nov 3, 2022 | −$68.00 | −$66.00 | +2.94% | $7.2M | SEC |
| Q2 2022 | Aug 4, 2022 | −$54.00 | −$66.00 | −22.22% | $6.7M | SEC |
| Q1 2022 | May 5, 2022 | −$44.84 | −$66.00 | −47.21% | $5.7M | SEC |
| Q4 2021 | Mar 1, 2022 | −$39.29 | −$48.00 | −22.18% | $6.3M | SEC |
| Q3 2021 | Nov 4, 2021 | −$34.55 | −$42.00 | −21.58% | $4.7M | SEC |
Quarterly revenue
Frequently asked questions
When did Bionano Genomics (BNGO) last report earnings?
Bionano Genomics last reported on Aug 10, 2026, covering fiscal Q2 2026.
Did BNGO beat earnings estimates?
Bionano Genomics reported EPS of −$0.67 for Q2 2026, in line with the −$0.67 consensus estimate.
How much revenue did BNGO report last quarter?
Bionano Genomics reported $8.2M in revenue for Q2 2026, against a consensus estimate of $7.6M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.